Link<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Xcell Therapeutics passes KOSDAQ technology evaluation…claims preliminary listing in September “Entering the global market in earnest after listing on KOSDAQ” Xcell Therapeutics, a company specializing in culture media for cell and gene therapy (CGT), announced today that it has passed the technology assessment for a special listing on KOSDAQ. Link<\/p>\n","protected":false},"author":1,"featured_media":5707,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[17],"tags":[],"class_list":["post-4232","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-new-products-technologies"],"acf":[],"yoast_head":"\n
Xcell Therapeutics Passes KOSDAQ Technology Evaluation<\/title>\n<meta name=\"description\" content=\"Xcell Therapeutics passes KOSDAQ technology evaluation...claims preliminary listing in September "Entering the global market in earnest after listing on KOSDAQ" Xcell Therapeutics, a company specializing in culture media for cell and gene therapy (CGT), announced today that it has passed the technology assessment for a special listing on KOSDAQ. Link\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/Xcell%20Therapeutics%20passes%20KOSDAQ%20technology%20evaluation...claims%20preliminary%20listing%20in%20September %20Entering%20the%20global%20market%20in%20earnest%20after%20listing%20on%20KOSDAQ %20Xcell%20Therapeutics,%20a%20company%20specializing%20in%20culture%20media%20for%20cell%20and%20gene%20therapy%20(CGT),%20announced%20today%20that%20it%20has%20passed%20the%20technology%20assessment%20for%20a%20special%20listing%20on%20KOSDAQ.%20Link\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Xcell Therapeutics Passes KOSDAQ Technology Evaluation\" \/>\n<meta property=\"og:description\" content=\"Xcell Therapeutics passes KOSDAQ technology evaluation...claims preliminary listing in September "Entering the global market in earnest after listing on KOSDAQ" Xcell Therapeutics, a company specializing in culture media for cell and gene therapy (CGT), announced today that it has passed the technology assessment for a special listing on KOSDAQ. Link\" \/>\n<meta property=\"og:url\" content=\"https:\/\/biogroupvietnam.com\/en\/new-products-technologies\/xcell-therapeutics-passes-kosdaq-technology-evaluation\/\" \/>\n<meta property=\"og:site_name\" content=\"Biogroup Vietnam\" \/>\n<meta property=\"article:published_time\" content=\"2024-02-25T10:22:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-02T10:40:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/biogroupvietnam.com\/wp-content\/uploads\/2025\/08\/3h0ONuYkFsSixjJU5nfhtU1gnxpc7fcSLEhLXZ9c.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"450\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/biogroupvietnam.com\/en\/new-products-technologies\/xcell-therapeutics-passes-kosdaq-technology-evaluation\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/biogroupvietnam.com\/en\/new-products-technologies\/xcell-therapeutics-passes-kosdaq-technology-evaluation\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/biogroupvietnam.com\/vi\/#\/schema\/person\/78a1c640012e6e7bc2bdf0d0fbffea95\"},\"headline\":\"Xcell Therapeutics Passes KOSDAQ Technology Evaluation\",\"datePublished\":\"2024-02-25T10:22:49+00:00\",\"dateModified\":\"2025-12-02T10:40:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/biogroupvietnam.com\/en\/new-products-technologies\/xcell-therapeutics-passes-kosdaq-technology-evaluation\/\"},\"wordCount\":834,\"image\":{\"@id\":\"https:\/\/biogroupvietnam.com\/en\/new-products-technologies\/xcell-therapeutics-passes-kosdaq-technology-evaluation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/biogroupvietnam.com\/wp-content\/uploads\/2025\/08\/3h0ONuYkFsSixjJU5nfhtU1gnxpc7fcSLEhLXZ9c.jpg\",\"articleSection\":[\"New Products & Technologies\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/biogroupvietnam.com\/en\/new-products-technologies\/xcell-therapeutics-passes-kosdaq-technology-evaluation\/\",\"url\":\"https:\/\/biogroupvietnam.com\/en\/new-products-technologies\/xcell-therapeutics-passes-kosdaq-technology-evaluation\/\",\"name\":\"Xcell Therapeutics v\u01b0\u1ee3t qua \u0111\u00e1nh gi\u00e1 c\u00f4ng ngh\u1ec7 tr\u00ean KOSDAQ\",\"isPartOf\":{\"@id\":\"https:\/\/biogroupvietnam.com\/vi\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/biogroupvietnam.com\/en\/new-products-technologies\/xcell-therapeutics-passes-kosdaq-technology-evaluation\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/biogroupvietnam.com\/en\/new-products-technologies\/xcell-therapeutics-passes-kosdaq-technology-evaluation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/biogroupvietnam.com\/wp-content\/uploads\/2025\/08\/3h0ONuYkFsSixjJU5nfhtU1gnxpc7fcSLEhLXZ9c.jpg\",\"datePublished\":\"2024-02-25T10:22:49+00:00\",\"dateModified\":\"2025-12-02T10:40:41+00:00\",\"author\":{\"@id\":\"https:\/\/biogroupvietnam.com\/vi\/#\/schema\/person\/78a1c640012e6e7bc2bdf0d0fbffea95\"},\"description\":\"Xcell Therapeutics - c\u00f4ng ty chuy\u00ean v\u1ec1 m\u00f4i tr\u01b0\u1eddng nu\u00f4i c\u1ea5y cho li\u1ec7u ph\u00e1p t\u1ebf b\u00e0o v\u00e0 gen (CGT), h\u1ecd \u0111\u00e3 v\u01b0\u1ee3t qua \u0111\u00e1nh gi\u00e1 c\u00f4ng ngh\u1ec7 \u0111\u1ec3 \u0111\u01b0\u1ee3c \u0111\u01b0a v\u00e0o danh s\u00e1ch \u0111\u1eb7c bi\u1ec7t tr\u00ean KOSDAQ.\",\"breadcrumb\":{\"@id\":\"https:\/\/biogroupvietnam.com\/en\/new-products-technologies\/xcell-therapeutics-passes-kosdaq-technology-evaluation\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/biogroupvietnam.com\/en\/new-products-technologies\/xcell-therapeutics-passes-kosdaq-technology-evaluation\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/biogroupvietnam.com\/en\/new-products-technologies\/xcell-therapeutics-passes-kosdaq-technology-evaluation\/#primaryimage\",\"url\":\"https:\/\/biogroupvietnam.com\/wp-content\/uploads\/2025\/08\/3h0ONuYkFsSixjJU5nfhtU1gnxpc7fcSLEhLXZ9c.jpg\",\"contentUrl\":\"https:\/\/biogroupvietnam.com\/wp-content\/uploads\/2025\/08\/3h0ONuYkFsSixjJU5nfhtU1gnxpc7fcSLEhLXZ9c.jpg\",\"width\":600,\"height\":450,\"caption\":\"Xcell Therapeutics Passes KOSDAQ Technology Evaluation\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/biogroupvietnam.com\/en\/new-products-technologies\/xcell-therapeutics-passes-kosdaq-technology-evaluation\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Biogroup Vietnam | End-to-End Biotechnology Solutions\",\"item\":\"https:\/\/biogroupvietnam.com\/vi\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"New Products & Technologies\",\"item\":\"https:\/\/biogroupvietnam.com\/vi\/su-kien-va-tin-tuc\/cong-nghe-san-pham-moi\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Xcell Therapeutics Passes KOSDAQ Technology Evaluation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/biogroupvietnam.com\/en\/vi\/#website\",\"url\":\"https:\/\/biogroupvietnam.com\/en\/vi\/\",\"name\":\"Biogroup Vietnam\",\"description\":\"Biogroup Vietnam cung c\u1ea5p d\u1ecbch v\u1ee5 k\u1ef9 thu\u1eadt c\u00f9ng thi\u1ebft b\u1ecb, v\u1eadt t\u01b0, h\u00f3a ch\u1ea5t v\u00e0 gi\u1ea3i ph\u00e1p sinh h\u1ecdc cho ph\u00f2ng th\u00ed nghi\u1ec7m c\u00f4ng ngh\u1ec7 sinh h\u1ecdc, y sinh v\u00e0 y h\u1ecdc t\u00e1i t\u1ea1o.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/biogroupvietnam.com\/en\/vi\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/biogroupvietnam.com\/vi\/#\/schema\/person\/78a1c640012e6e7bc2bdf0d0fbffea95\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/biogroupvietnam.com\/vi\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/biogroupvietnam.com\/wp-content\/litespeed\/avatar\/eb8a826cba57879e3cdbbc4f5ece34eb.jpg?ver=1776157819\",\"contentUrl\":\"https:\/\/biogroupvietnam.com\/wp-content\/litespeed\/avatar\/eb8a826cba57879e3cdbbc4f5ece34eb.jpg?ver=1776157819\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/freshfromnature.vn\/\"],\"url\":\"https:\/\/biogroupvietnam.com\/en\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Xcell Therapeutics Passes KOSDAQ Technology Evaluation","description":"Xcell Therapeutics passes KOSDAQ technology evaluation...claims preliminary listing in September \"Entering the global market in earnest after listing on KOSDAQ\" Xcell Therapeutics, a company specializing in culture media for cell and gene therapy (CGT), announced today that it has passed the technology assessment for a special listing on KOSDAQ. Link","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"Xcell Therapeutics passes KOSDAQ technology evaluation...claims preliminary listing in September \"Entering the global market in earnest after listing on KOSDAQ\" Xcell Therapeutics, a company specializing in culture media for cell and gene therapy (CGT), announced today that it has passed the technology assessment for a special listing on KOSDAQ. Link","og_locale":"en_US","og_type":"article","og_title":"Xcell Therapeutics Passes KOSDAQ Technology Evaluation","og_description":"Xcell Therapeutics passes KOSDAQ technology evaluation...claims preliminary listing in September \"Entering the global market in earnest after listing on KOSDAQ\" Xcell Therapeutics, a company specializing in culture media for cell and gene therapy (CGT), announced today that it has passed the technology assessment for a special listing on KOSDAQ. Link","og_url":"https:\/\/biogroupvietnam.com\/en\/new-products-technologies\/xcell-therapeutics-passes-kosdaq-technology-evaluation\/","og_site_name":"Biogroup Vietnam","article_published_time":"2024-02-25T10:22:49+00:00","article_modified_time":"2025-12-02T10:40:41+00:00","og_image":[{"width":600,"height":450,"url":"https:\/\/biogroupvietnam.com\/wp-content\/uploads\/2025\/08\/3h0ONuYkFsSixjJU5nfhtU1gnxpc7fcSLEhLXZ9c.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/biogroupvietnam.com\/en\/new-products-technologies\/xcell-therapeutics-passes-kosdaq-technology-evaluation\/#article","isPartOf":{"@id":"https:\/\/biogroupvietnam.com\/en\/new-products-technologies\/xcell-therapeutics-passes-kosdaq-technology-evaluation\/"},"author":{"name":"admin","@id":"https:\/\/biogroupvietnam.com\/vi\/#\/schema\/person\/78a1c640012e6e7bc2bdf0d0fbffea95"},"headline":"Xcell Therapeutics Passes KOSDAQ Technology Evaluation","datePublished":"2024-02-25T10:22:49+00:00","dateModified":"2025-12-02T10:40:41+00:00","mainEntityOfPage":{"@id":"https:\/\/biogroupvietnam.com\/en\/new-products-technologies\/xcell-therapeutics-passes-kosdaq-technology-evaluation\/"},"wordCount":834,"image":{"@id":"https:\/\/biogroupvietnam.com\/en\/new-products-technologies\/xcell-therapeutics-passes-kosdaq-technology-evaluation\/#primaryimage"},"thumbnailUrl":"https:\/\/biogroupvietnam.com\/wp-content\/uploads\/2025\/08\/3h0ONuYkFsSixjJU5nfhtU1gnxpc7fcSLEhLXZ9c.jpg","articleSection":["New Products & Technologies"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/biogroupvietnam.com\/en\/new-products-technologies\/xcell-therapeutics-passes-kosdaq-technology-evaluation\/","url":"https:\/\/biogroupvietnam.com\/en\/new-products-technologies\/xcell-therapeutics-passes-kosdaq-technology-evaluation\/","name":"Xcell Therapeutics v\u01b0\u1ee3t qua \u0111\u00e1nh gi\u00e1 c\u00f4ng ngh\u1ec7 tr\u00ean KOSDAQ","isPartOf":{"@id":"https:\/\/biogroupvietnam.com\/vi\/#website"},"primaryImageOfPage":{"@id":"https:\/\/biogroupvietnam.com\/en\/new-products-technologies\/xcell-therapeutics-passes-kosdaq-technology-evaluation\/#primaryimage"},"image":{"@id":"https:\/\/biogroupvietnam.com\/en\/new-products-technologies\/xcell-therapeutics-passes-kosdaq-technology-evaluation\/#primaryimage"},"thumbnailUrl":"https:\/\/biogroupvietnam.com\/wp-content\/uploads\/2025\/08\/3h0ONuYkFsSixjJU5nfhtU1gnxpc7fcSLEhLXZ9c.jpg","datePublished":"2024-02-25T10:22:49+00:00","dateModified":"2025-12-02T10:40:41+00:00","author":{"@id":"https:\/\/biogroupvietnam.com\/vi\/#\/schema\/person\/78a1c640012e6e7bc2bdf0d0fbffea95"},"description":"Xcell Therapeutics - c\u00f4ng ty chuy\u00ean v\u1ec1 m\u00f4i tr\u01b0\u1eddng nu\u00f4i c\u1ea5y cho li\u1ec7u ph\u00e1p t\u1ebf b\u00e0o v\u00e0 gen (CGT), h\u1ecd \u0111\u00e3 v\u01b0\u1ee3t qua \u0111\u00e1nh gi\u00e1 c\u00f4ng ngh\u1ec7 \u0111\u1ec3 \u0111\u01b0\u1ee3c \u0111\u01b0a v\u00e0o danh s\u00e1ch \u0111\u1eb7c bi\u1ec7t tr\u00ean KOSDAQ.","breadcrumb":{"@id":"https:\/\/biogroupvietnam.com\/en\/new-products-technologies\/xcell-therapeutics-passes-kosdaq-technology-evaluation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/biogroupvietnam.com\/en\/new-products-technologies\/xcell-therapeutics-passes-kosdaq-technology-evaluation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/biogroupvietnam.com\/en\/new-products-technologies\/xcell-therapeutics-passes-kosdaq-technology-evaluation\/#primaryimage","url":"https:\/\/biogroupvietnam.com\/wp-content\/uploads\/2025\/08\/3h0ONuYkFsSixjJU5nfhtU1gnxpc7fcSLEhLXZ9c.jpg","contentUrl":"https:\/\/biogroupvietnam.com\/wp-content\/uploads\/2025\/08\/3h0ONuYkFsSixjJU5nfhtU1gnxpc7fcSLEhLXZ9c.jpg","width":600,"height":450,"caption":"Xcell Therapeutics Passes KOSDAQ Technology Evaluation"},{"@type":"BreadcrumbList","@id":"https:\/\/biogroupvietnam.com\/en\/new-products-technologies\/xcell-therapeutics-passes-kosdaq-technology-evaluation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Biogroup Vietnam | End-to-End Biotechnology Solutions","item":"https:\/\/biogroupvietnam.com\/vi\/"},{"@type":"ListItem","position":2,"name":"New Products & Technologies","item":"https:\/\/biogroupvietnam.com\/vi\/su-kien-va-tin-tuc\/cong-nghe-san-pham-moi\/"},{"@type":"ListItem","position":3,"name":"Xcell Therapeutics Passes KOSDAQ Technology Evaluation"}]},{"@type":"WebSite","@id":"https:\/\/biogroupvietnam.com\/en\/vi\/#website","url":"https:\/\/biogroupvietnam.com\/en\/vi\/","name":"Biogroup Vietnam","description":"Biogroup Vietnam cung c\u1ea5p d\u1ecbch v\u1ee5 k\u1ef9 thu\u1eadt c\u00f9ng thi\u1ebft b\u1ecb, v\u1eadt t\u01b0, h\u00f3a ch\u1ea5t v\u00e0 gi\u1ea3i ph\u00e1p sinh h\u1ecdc cho ph\u00f2ng th\u00ed nghi\u1ec7m c\u00f4ng ngh\u1ec7 sinh h\u1ecdc, y sinh v\u00e0 y h\u1ecdc t\u00e1i t\u1ea1o.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/biogroupvietnam.com\/en\/vi\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/biogroupvietnam.com\/vi\/#\/schema\/person\/78a1c640012e6e7bc2bdf0d0fbffea95","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/biogroupvietnam.com\/vi\/#\/schema\/person\/image\/","url":"https:\/\/biogroupvietnam.com\/wp-content\/litespeed\/avatar\/eb8a826cba57879e3cdbbc4f5ece34eb.jpg?ver=1776157819","contentUrl":"https:\/\/biogroupvietnam.com\/wp-content\/litespeed\/avatar\/eb8a826cba57879e3cdbbc4f5ece34eb.jpg?ver=1776157819","caption":"admin"},"sameAs":["https:\/\/freshfromnature.vn\/"],"url":"https:\/\/biogroupvietnam.com\/en\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/biogroupvietnam.com\/en\/wp-json\/wp\/v2\/posts\/4232","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/biogroupvietnam.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/biogroupvietnam.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/biogroupvietnam.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/biogroupvietnam.com\/en\/wp-json\/wp\/v2\/comments?post=4232"}],"version-history":[{"count":5,"href":"https:\/\/biogroupvietnam.com\/en\/wp-json\/wp\/v2\/posts\/4232\/revisions"}],"predecessor-version":[{"id":9177,"href":"https:\/\/biogroupvietnam.com\/en\/wp-json\/wp\/v2\/posts\/4232\/revisions\/9177"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/biogroupvietnam.com\/en\/wp-json\/wp\/v2\/media\/5707"}],"wp:attachment":[{"href":"https:\/\/biogroupvietnam.com\/en\/wp-json\/wp\/v2\/media?parent=4232"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/biogroupvietnam.com\/en\/wp-json\/wp\/v2\/categories?post=4232"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/biogroupvietnam.com\/en\/wp-json\/wp\/v2\/tags?post=4232"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}